OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 223.7% based on the discounted cash flow analysis.
| Market cap | $5.76 Billion |
|---|---|
| Enterprise Value | $1.39 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.34 |
| Outstanding Shares | 298,184,000 |
| P/E Ratio | -168.13 |
|---|---|
| PEG | -114.63 |
| Price to Sales | 0.47 |
| Price to Book Ratio | 4.1 |
| Enterprise Value to Revenue | 0.1 |
| Enterprise Value to EBIT | 80.91 |
| Enterprise Value to Net Income | -36 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.26 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0730▲ 7.50% |
|---|---|
| Total Calls | 11,243,700▼ 27.31% |
| Total Puts | 12,064,300▼ 21.85% |
Holdings and activity of institutional investors.
| Ownership % | 61.60%▼ 3.42% |
|---|---|
| Total Invested | $2.00B▼ 17.24% |
| Investors Holding | 364▼ 12.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...